logo

For the Inventor, By the Inventor

Harlow, United Kingdom

David Kenneth Dean

This inventor holds 17 USPTO granted patents and 4 published patent applications and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Smithkline Beecham Corporation, Glaxo Group Limited. Active years: 1998-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Kenneth Dean. Retrieved from https://idiyas.com/inventor/david-kenneth-dean

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 23.5

 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Dorking, GB (1998)
  • Harlow, GB (2006 - 2013)

Company Filing History:

goldMedal11 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal6 out of 1,170 
 
Glaxo Group Limited
 patents

Years Active: 1998-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
P2X7 Modulators
Raf Kinase Inhibitors
Benzazepine Derivatives
Heterocyclic Compounds
Antimicrobial Activity
Neurological Disorders
Gastrointestinal Disorders
Nitrogen-Containing Derivatives
Pyridine Derivatives
Imidazole Derivatives
17 patents (USPTO):Explore Patents
1. 8513248 - 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators (2013-08-20),
2. 8501946 - 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators (2013-08-06),
3. 8207331 - Benzazepine derivatives for the treatment of neurological disorders (2012-06-26),
4. 7932282 - Imidazolidine carboxamide derivatives as P2X7 modulators (2011-04-26),
5. 7799773 - Benzazepine derivatives for the treatment of neurological disorders (2010-09-21),
6. 7452906 - Pyridine derivatives as Raf kinase inhibitors (2008-11-18),
7. 7446106 - Pyridylfurans and pyrroles as Raf kinase inhibitors (2008-11-04),
8. 7381728 - Piperazine derivatives useful for the treatment of gastrointestinal disorders (2008-06-03),
9. 7375105 - Pyridine substituted furan derivatives as Raf kinase inhibitors (2008-05-20),
10. 7297694 - Pyridylfurans and pyrroles as Raf kinase inhibitors (2007-11-20),
11. 7297693 - Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors (2007-11-20),
12. 7282500 - Imidazole-2-carboxamide derivatives as Raf kinase inhibitors (2007-10-16),
13. 7199137 - Imidazole derivatives as Raf kinase inhibitors (2007-04-03),
14. 7045524 - Pleuromutilin derivatives with antimicrobial activity (2006-05-16),
15. 7026336 - Compounds (2006-04-11),

Title: David Kenneth Dean - Pioneering Inventor from Harlow, GB

Introduction: David Kenneth Dean is a distinguished inventor hailing from Harlow, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: David Kenneth Dean holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, David Kenneth Dean has consistently pushed the boundaries of innovation, with a focus on developing cutting-edge technologies that have revolutionized industries.

Collaborations: David Kenneth Dean has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing to drive progress in the field of technology.

Conclusion: David Kenneth Dean's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…